Observational studyJournal of cardiovascular electrophysiology2026
Comparison of Spatio-Temporal Dispersion Electrogram Ablation and Low Voltage Zone Ablation in Patients With Persistent Atrial Fibrillation.
Observational study in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary vein isolation (PVI) alone was less effective for patients with persistent atrial fibrillation (AF) compared to those with paroxysmal AF. Although the TAILORED AF trial demonstrated the efficacy of spatio-temporal dispersion electrogram (STDE) ablation as additional treatment for PVI, comparisons between STDE and low-voltage zone (LVZ) remain unclear. We compared the efficacy of two different methods beyond PVI: the STDE and the LVZ ablation.
methodsThis retrospective observational study included 107 consecutive patients (median age, 71 years; 79 male) who underwent initial catheter ablation for persistent AF at our institution. STDE evaluation and STDE-guided substrate modification were performed in the STDE ablation group (n = 53). The historical control group (n = 54) did not undergo STDE evaluation and received additional ablation based on the LVZ. The primary endpoint was the recurrence of atrial arrhythmias after the ablation up to 24 months, with a 3-month blanking period applied.
resultsThe number of additional ablations, including linear ablation, posterior wall isolation, and focal ablation, was significantly higher in the STDE group. The AF-free survival rate at 24 months follow-up after ablation was higher in the STDE group (76.3% vs. 58.4%; p = 0.027). In the multivariate Cox proportional regression analysis, prolonged AF duration (hazard ratio [HR] 1.37, 95% confidence interval [CI] 1.16-1.61; p < 0.001) and larger left atrial size (HR: 1.11, 95% CI: 1.02-1.20; p = 0.012) were independent predictors of AF recurrence. Conversely, STDE ablation was independently associated with a significantly lower risk of recurrence (HR: 0.29, 95% CI: 0.12-0.66; p = 0.004).
conclusionSTDE was associated with a lower risk of AF recurrence than PVI with LVZ ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.